|
 |
Metformin HydrochlorideThis page contains recent news articles, when available, and an overview of Metformin Hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The active substances of Ristfor (A10BD07), a combination product of oral blood glucose-lowering drugs, are sitagliptin and metformin hydrochloride. ... PharmaLive.com (press release) EU Panel Backs DuoCover From Bristol-Myers Squibb Pharma - Dec 18, 2009 Ristfor (sitagliptin / metformin hydrochloride), from Merck Sharp & Dohme Ltd, intended for the treatment of type 2 diabetes mellitus. ... Wall Street Journal Santarus Submits IND for Phase III Clinical Testing of Rifamycin SV MMX in ... - Dec 31, 2009 ...which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA® (metformin hydrochloride extended release tablets), ... PharmiWeb.com (press release) Santarus Receives Previously Announced $20 Million Milestone for FDA Approval ... - Dec 22, 2009 ...which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA(R) (metformin hydrochloride extended release tablets), ... FOXBusiness Santarus Announces Webcast Presentation at the Lippert/Heilshorn Life Sciences ... - Dec 14, 2009 ...which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA ® (metformin hydrochloride extended release tablets), ... Behavioral Health Central (blog) Sign Up For Our Free Newsletter!! AGRT,ACTG,ZAGG,SNTS,CTIC,BLDP - Dec 22, 2009 ...which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA(R) (metformin hydrochloride extended release tablets), ... TMC Net Santarus to Present at Lazard Capital Markets 6th Annual Healthcare Conference - Nov 10, 2009 ...which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA ® (metformin hydrochloride extended release tablets), ... WELT ONLINE Depomed Reports Third Quarter 2009 Financial Results - Oct 29, 2009 GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, ... Reuters Depomed to Present at Merriman Curhan Ford`s Investor Summit 2009 - Nov 3, 2009 GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, ... Reuters Santarus Reports Third Quarter 2009 Financial Results - Nov 4, 2009 ...which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA ® (metformin hydrochloride extended release tablets), ... WELT ONLINE Depomed Q3 Financial Results (NASDAQ:DEPO) - Oct 30, 2009 Depomed's GLUMETZA (metformin hydrochloride extended release tablets) has already been approved for use in adults with Type 2 diabetes and the prescriptions ... FavStocks (blog) Positive Data from Two Investigator-Initiated Studies with Santarus` ZEGERID ... - Oct 26, 2009 ...which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA® (metformin hydrochloride extended release tablets), ... Reuters Depomed, Inc. to Announce Third Quarter 2009 Financial Results on October 29, 2009 - Oct 22, 2009 GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, ... Reuters Merck Announces Third-Quarter 2009 Financial Results - Oct 22, 2009 JANUMET (sitagliptin/metformin hydrochloride), a single tablet that targets all three key defects of type 2 diabetes, achieved worldwide sales of $173 ... Reuters Healthy lifestyle, cheap pill could help keep diabetes at bay for a decade - Oct 29, 2009 Prediction: .. http://bit.ly/10javq KickOutADDADHD Drug interactions of Motrin, Lisinopril, Metformin Hydrochloride ...: Real world drug outcomes: Drug ... Gaea Times NASDAQ - Depomed, Inc. to Announce Third Quarter 2009 Financial Results on ... - Oct 22, 2009 GLUMETZA (R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, ... Ad-Hoc-News (Pressemitteilung) Santarus Ranked Number 23 Fastest Growing Company in North America on ... - Oct 20, 2009 ...which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA(R) (metformin hydrochloride extended release tablets), ... Trading Markets (press release) … announces FDA approval for Glipizide and Metformin Hydrochloride … - Apr 14, 2007 Glipizide and Metformin Hydrochloride Tablets are the generic version of Bristol Myers Squibb's Metaglip(TM) Tablets. Glipizide and Metformin Hydrochloride ... News-Medical.net … ANDA approvals for Mometasone Furoate and Metformin Hydrochloride - May 30, 2008 The total sales for Metformin Hydrochloride tablets in the 12 month period ending March 2008 were in excess of USD $ 158 million as per IMS Health. ... Equity Bulls Sun Pharma US arm told to recall diabetes drug - Mar 25, 2008 Metformin Hydrochloride, a bio-equivalent of Bristol Myers Squibb's Glucophage, was launched by Caraco in the US in February 2002. ... Rediff METFORMIN (Oral route) - met-FOR-min.(Drug overview) - May 1, 2007 Metformin hydrochloride treatment should not be initiated in patients greater ... In addition, metformin hydrochloride should be promptly withheld in the ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Ranbaxy gets FDA nod for anti-diabetic drug - Jul 5, 2005 Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in patients with Type-2 ... Hindu Business Line Avandia: Getting the Facts - May 22, 2007 Metformin hydrochloride can cause a rare but serious side effect called lactic acidosis, which is a build-up of lactic acid in the blood that can cause ... FOXNews … FDA Approval for Metformin Hydrochloride Extended Release Tablets,... - Apr 15, 2005 ...has received final approval from the United States Food and Drug Administration for metformin hydrochloride extended-release tablets, 750 mg. ... $4.95 - PR Newswire - ECNext … Pharma receives Certificate of suitability for Metformin Hydrochlor... - Jul 29, 2008 Marksans Pharma Ltd has announced that the Company has received Certificate of suitability for Metformin Hydrochloride drug substance from the European ... Equity Bulls … LIQUID METFORMIN HYDROCHLORIDE LAUNCHED BY ROSEMONT - Aug 9, 2007 Rosemont's 150ml liquid Metformin Hydrochloride 500mg/5ml has just been granted a licence by the MHRA. The news will be welcomed by community pharmacists ... Healthcare Republic - Healthcare Republic … Organics receives approval from EDQM for Metformin Hydrochloride - Feb 25, 2008 This certificate will strengthen the Company to enter the European Regulated Market for Metformin Hydrochloride. This certificate will have a substantial ... Equity Bulls Stocks Under $10 Weekly Summary - Jan 20, 2006 In a patent suit filed last week against Ivax (IVX:Amex), DepoMed is alleging that Ivax's diabetes treatment, extended release metformin hydrochloride, ... TheStreet.com - TheStreet.com (subscription) Metformin-BC - Metformin hydrochloride - Medical Drug - Apr 7, 2006 Metformin is a blood sugar lowering agent, used for the treatment of diabetes mellitus type 2 in adults, when dietary management and exercise alone do not ... Virtual Medical Centre - The Virtual Medical Centre … FDA Approval for Metformin Hydrochloride Extended Release Tablets,... - Apr 15, 2005 Alpharma Receives FDA Approval for Metformin Hydrochloride Extended Release Tablets, 750mg. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Marksans Pharma gets nod for Metformin Hydrochloride - Aug 12, 2008 Marksans Pharma has received Certificate of suitability for Metformin Hydrochloride drug substance from the European Directorate for the Quality of ... Myiris.com Mylan Announces Approval for Metformin Hydrochloride Extended- … - Sep 14, 2005 PITTSBURGH, Sept. 14 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. today announced that Mylan Pharmaceuticals Inc. has received final approval from the ... $4.95 - PR Newswire - ECNext FDA allows sale of Ranbaxy tablets in the US - Aug 13, 2007 Ipca Laboratories, which is setting up a new manufacturing unit at Indore, would manufacture Metformin Hydrochloride in India, the information given to the ... Indian Muslims Depomed Settles Patent Litigation Against IVAX - Apr 7, 2008 6340475 and 6635280) by IVAX's extended release metformin hydrochloride tablets. ... Glumetza(R) (metformin hydrochloride extended release tablets) is ... Genetic Engineering News - Genetic Engineering News (press release) Generic name: Metformin hydrochloride - Dec 1, 2005 Glucophage is an oral antidiabetic medication used to treat type 2 (non-insulin-dependent) diabetes. Diabetes develops when the body proves unable to burn ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com FDA's thumbs up to PFI reverberates through outsourcing industry - Aug 30, 2006 In the production of metformin hydrochloride, a diabetes drug, the company is partnering with US firm Amneal Pharmaceuticals for the raw material supply. ... In-PharmaTechnologist.com Press Release: Ranbaxy Gains Approval to Market Pseudoephedrine … - Sep 29, 2005 Article: Barr Receives Tentative Approval for Metformin Hydrochloride . ... Metformin Hydrochloride extended-release tablets will compete in a market that ... Pay-Per-View - PR Newswire - HighBeam Research Court Grants Depomed's Motion for Summary Judgment of Patent … - Dec 13, 2007 6340475 and 6635280 by IVAX's extended release metformin hydrochloride tablets. ... GLUMETZA(TM) (metformin hydrochloride extended release tablets) is ... Free with registration - Business Wire - AccessMyLibrary.com Glenmark Generics receives ANDA approvals - Jun 30, 2008 Metformin hydrochloride tablets as monotherapy are indicated as an adjunct to ... The total sales for metformin hydrochloride tablets in the 12 month period ... Express Pharma Depomed and King Pharmaceuticals Prepare for Launch of Glumetza(TM … - Aug 23, 2006 In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is ... Free with registration - Business Wire - AccessMyLibrary.com Health Canada Approves Glumetza (Metformin) to Treat Type II Diabetes - Jun 1, 2005 Glumetza (metformin hydrochloride) extended-release tablets in 500mg and 1000mg dosage strengths are indicated for the control of hyperglycemia in adult ... DG News Teva Announces Approval of Glipizide and Metformin HCL Tablets - Oct 31, 2005 Teva's Glipizide and Metformin Hydrochloride Tablets are the AB-rated generic equivalent of Bristol-Myers Squibb's Metaglip(R) Tablets, which are indicated ... RedOrbit Company Profile Report - Sep 30, 2006 Andrx Pharmaceuticals Metformin Hydrochloride Extended Release; Andrx Pharmaceuticals Metformin Hydrochloride. Biguanides/Peroxisome Proliferator-Activated ... $50.00 - Revere Reports - Revere Depomed Says FDA Approves 1000 mg Strength Tablets of Glumetza - Jan 2, 2008 Glumetza (metformin hydrochloride extended release tablets) is indicated alone or in combination with a sulfonylurea or insulin as an adjunct to diet and ... FierceBiotech IPCA-RANBAXY ALLIANCE GETS USFDA NOD FOR DIABETIC DRUG. - Aug 14, 2007 The approval was given for Metformin Hydrochloride USP tablets in multiple strengths of 500 mg, 850 mg and 1000 mg in the US market, Ipca said. ... $4.95 - AsiaPulse News - ECNext Depomed Files Prior Approval Supplement for 1000 Mg Strength Tablets ... - Apr 2, 2007 Glumetzaâ„¢ (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United States ... RedOrbit Depomed Announces Sweeping Interim Victory in Litigation against Ivax - Dec 20, 2006 6340475 and 6635280 by Ivax's extended release metformin hydrochloride tablets. ... In addition, once daily Glumetza(TM) (metformin hydrochloride extended ... Genetic Engineering News - Genetic Engineering News (press release) Santarus and Depomed Announce US Promotion Agreement for … - Jul 22, 2008 GLUMETZA (metformin hydrochloride extended release tablets) is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients ... RedOrbit Generic Drugs; US FDA grants approval of generics for type 2 diabetes - Dec 5, 2005 Teva's Glipizide and Metformin Hydrochloride Tablets are the AB-rated generic equivalent of Bristol-Myers Squibb's Metaglip Tablets, which are indicated as ... Pay-Per-View - Obesity & Diabetes Week - Factiva, from Dow Jones Drug/Medical Device - Sep 30, 2006 Andrx Pharmaceuticals Metformin Hydrochloride Extended Release, Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type 2 Diabetes, Diarrhea, Nausea, Vomiting, ... $70.00 - Revere Reports - Revere Press Release: INVEGA(R) Receives Positive Opinion From European … - Apr 27, 2007 Article: Barr Receives Tentative Approval for Metformin Hydrochloride . ... Metformin Hydrochloride extended-release tablets will compete in a market that ... Pay-Per-View - PR Newswire - HighBeam Research New Once-Daily Oral Diabetes Treatment Glumetza(TM) Now Available - Sep 6, 2006 Glumetza(TM) (metformin hydrochloride extended-release tablets) is indicated alone or in combination with sulfonylurea or insulin as an adjunct to diet and ... RedOrbit Press Release: Depomed Inc. Receives Progressive Follow. - M2 … - Jan 2, 2008 Glumetza (metformin hydrochloride extended release tablets) is indicated alone or in combination with a sulfonylurea or insulin as an adjunct to diet and ... Pay-Per-View - M2 Presswire - HighBeam Research New Patient Support Program Offers Savings on Glumetza(TM) Therapy … - Nov 21, 2006 Glumetza(TM) (metformin hydrochloride extended-release tablets) is indicated alone or in combination with sulfonylurea or insulin as an adjunct to diet and ... Genetic Engineering News - Genetic Engineering News (press release) Press Release: Alpharma Settles Gabapentin Exclusivity Litigation. -... - Feb 11, 2005 ..."Our U.S. generics business continues ... million related to the 2003 agreement with Ivax Corporation for metformin hydrochloride ... ... Pay-Per-View - PR Newswire - HighBeam Research Contributing to the Fight against Diabetes is Only a Click Away... - Nov 15, 2006 Glumetza(TM) (metformin hydrochloride extended-release tablets) is indicated alone or in combination with sulfonylurea or insulin as an adjunct to diet and ... Genetic Engineering News - Genetic Engineering News (press release) IN BRIEF: The MHRA has granted a licence.(United Kingdom. Medicines … - Aug 11, 2007 The MHRA has granted a licence for a liquid version of metformin hydrochloride. Rosemont's 150ml liquid metformin hydrochloride 500mg/5m (previously only ... Free with registration - Chemist & Druggist - AccessMyLibrary.com Santarus Commences GLUMETZA Promotion - Oct 10, 2008 Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that it has commenced promotion of GLUMETZA(R) (metformin hydrochloride ... RedOrbit Teva receives US FDA approval of glipizide and metformin HCl tabs - Nov 5, 2005 Teva's glipizide and metformin hydrochloride tablets are the AB-rated generic equivalent of Bristol-Myers Squibb's Metaglip tablets, which are indicated as ... pharmabiz.com Biovail Announces Canadian Commercial Availability of 1,000mg Dosage … - Jan 24, 2008 Glumetza[TM] (metformin hydrochloride) extended-release tablets in 500mg and 1000mg dosage strengths are indicated for the control of hyperglycemia in adult ... Free with registration - Business Wire - AccessMyLibrary.com Solvay's Fournier withdraws marketing application for Synordia - EMEA - Dec 8, 2006 ...owned by Belgian chemicals group Solvay SA, was withdrawing its marketing authorisation application for Synordia (fenofibrate/metformin hydrochloride). ... Forbes IN BRIEF: The MHRA has granted a licence.(United Kingdom. Medicines … - Aug 11, 2007 The MHRA has granted a licence for a liquid version of metformin hydrochloride. Rosemont's 150ml liquid metformin hydrochloride 500mg/5m (previously only ... $4.95 - Chemist & Druggist - ECNext Two Merck Medicines Recommended For Approval In The European … - Apr 27, 2008 For patients taking metformin 850 mg twice daily, the recommended starting dose of JANUMET is 50 mg sitagliptin/1000 mg metformin hydrochloride twice daily. ... Medical News Today - Medical News Today (press release) Factiva Search - Aug 24, 2006 New and generic drug approvals: Metformin Hydrochloride Tablets. 24 August, 2006 US Food and Drug Administration News ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones Depomed Settles Patent Litigation Against IVAX - Aug 4, 2008 6340475 and 6635280) by IVAX's extended release metformin hydrochloride tablets. The parties have entered into a settlement and license agreement that ... ag-IP-news Agency Press Release: New Data Demonstrate Benefits of Initial Use of … - Jun 10, 2006 The box will state ... metformin hydrochloride), and Avandaryl (rosiglitazone maleate and ... most patients with type 2 diabetes when used appropriately ... Pay-Per-View - PR Newswire - HighBeam Research Article: New details regarding [B.sub.12] deficiency in diabetics... - Mar 1, 2007 Article: Metformin hydrochloride extended-release tablets now ... Diabetes Week; December 22, 2003 ; 628 words ... ... by another generic company. ... Pay-Per-View - Original Internist - HighBeam Research Caraco Pharma gets FDA OK for generic Metaglip - Jan 14, 2008 The approval is for glipizide/metformin hydrochloride tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg, the company said in a statement. ... Reuters FDA panel OKs Bristol-Myers diabetes drug - Sep 9, 2005 The panel also recommended that Pargluva be used alone or in combination with Bristol-Myers' (NYSE:BMY) Glucophage, also known as metformin hydrochloride. ... MarketWatch Company Profile Report - Aug 2, 2008 Metformin Hydrochloride; Metformin Hydrochloride Extended-Release. Intermediary Metabolism Disorders. Gout. Gouty Arthritis. Non-Steroidal Anti-Inflammatory ... $50.00 - Revere Reports - Revere Company Profile Report - Aug 2, 2008 Metformin Hydrochloride; Metformin Hydrochloride Extended-Release. Intermediary Metabolism Disorders. Gout. Gouty Arthritis. Non-Steroidal Anti-Inflammatory ... $50.00 - Revere - Alacra Store Granules, Amneal Pharma get FDA nod - Aug 2, 2006 States have received the approval for their abbreviated new drug application (ANDA) of Metformin Hydrochloride tablets of 500 mg, 850 mg and 1000 mg. ... Business Standard Press Release: Alpharma Names Dean J. Mitchell President and CEO. - … - Jun 1, 2006 Article: Alpharma Receives FDA Approval for Metformin Hydrochloride ... PR Newswire; April 15, 2005 ; 627 words ... ... PRNewswire-FirstCall/ -- Alpharma ... Pay-Per-View - PR Newswire - HighBeam Research Indian shares trade firm; credit crunch worries fan volatility - Aug 13, 2007 ...its alliance with IPCA Laboratories Ltd securing Food and Drugs Administration approval making and marketing Metformin hydrochloride tablets in the US. ... Forbes US FDA approves Glenmark's metformin tablets - May 30, 2008 MUMBAI (Reuters) - The US Food and Drug Administration has approved Glenmark Pharmaceuticals Ltd's diabetes drug metformin hydrochloride tablets in multiple ... Reuters Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to … - Sep 25, 2007 Glumetza[TM] (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United ... Free with registration - Business Wire - AccessMyLibrary.com BUSINESS BRIEFING - Dec 30, 2005 Apotex Corp., whose U.S. headquarters is in Weston, said it received final approval from the Food and Drug Administration for metformin hydrochloride ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Indian shares little changed in early deals; Hindalco, Sterlite gain - Mar 26, 2008 The company's US subsidiary was reportedly asked to withdraw batches of its diabetic-curing generic Metformin Hydrochloride tablets by the FDA on efficacy ... Forbes Brussels shares close higher as Suez, KBC and UCB rise UPDATE - Dec 8, 2006 ...unit Fournier Laboratories Ireland Ltd was withdrawing its marketing authorisation application for Synordia (fenofibrate/metformin hydrochloride). ... Forbes Drug Development; FDA grants approvable letter for extended-release … - Apr 3, 2005 Drug Application (NDA) for Glumetza, a once-daily, extended-release formulation of metformin hydrochloride (HCl) for the treatment of Type II diabetes. ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Do the math: Same drugs, lower price - Jan 15, 2006 For example, Metformin hydrochloride, a diabetes drug, cost $18 at Johnson compared with $88.19 at Walgreens and $85.59 at CVS at the same quantity and ... Boston Globe Depomed Reports Published Data on Improved Glycemic Control in … - Jun 7, 2006 Depomed, Inc. (Nasdaq:DEPO) announced today that the results of a second Phase 3 clinical trial with Glumetza(TM) (metformin hydrochloride extended-release ... Genetic Engineering News - Genetic Engineering News (press release) Depomed to Announce Third Quarter 2007 Financial Results on … - Nov 1, 2007 Glumetzaâ„¢ (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United States ... businesswire.com Depomed Announces Equity Financing Commitment of Up to $30 Million - Dec 12, 2006 In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Receives $10 Million License Fee from Esprit and Withdraws … - Dec 21, 2006 In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Delivers Notice of Breach and Demand for Arbitration to... - Dec 18, 2006 In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Reports 2006 Year End Financial Results - Mar 14, 2007 In addition, $526000 was in product sales of Glumetza(TM) (metformin hydrochloride extended release tablets) through King Pharmaceuticals and $109000 was ... Genetic Engineering News - Genetic Engineering News (press release) Depomed to Announce First Quarter 2007 Financial Results on Tuesday, ... - Apr 24, 2007 Glumetza(TM) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United ... Genetic Engineering News - Genetic Engineering News (press release) OTCPicks.com Stocks to Watch for Friday, November 21st DEPO - Nov 21, 2008 GLUMETZA® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Inc. in the United ... TransWorldNews - TransWorldNews (press release) EMEA statement following seizure of Avandamet tablets by US Food and ... - Mar 7, 2005 Avandamet is a combination of Rosiglitazone maleate and metformin hydrochloride; both components are available individually in Europe. Medical News Today - Medical News Today (press release) Market Live from BSE - NSE, Latest Market Commentary | Economic … - May 30, 2008 0.1 per cent and Metformin Hydrochloride tablets USP 500 mg, 850 mg, and 1000 mg and will soon commence marketing and distribution of these products in ... Economic Times FDA finds dozens new deficiencies at Andrx. - Apr 25, 2006 Metformin Hydrochloride Extended Release is generic Glucophage XR; Diltia XT is generic Dilacor XR; and Ketoprofen ER is generic Oruvail. ... Free with registration - South Florida Sun - Sentinel - AccessMyLibrary.com Sweet extension - Dec 23, 2007 AN extended-release version of glucophage (metformin hydrochloride tablets) used to help control blood sugar levels in type 2 diabetes was launched by Merck ... Malaysia Star Genetic Variants of the Organic Cation Transporter 2 Influence the … - Oct 9, 2007 Klepser, TB & Kelly, MW Metformin hydrochloride: an antihyperglycemic agent. Am. J. Health. Syst. Pharm. 54, 893–903 (1997). | PubMed | ChemPort | ... Nature.com Lactic acidosis in an HIV-infected patient receiving highly active … - Jun 15, 2005 Given that the patient did not have a previous history of inherited mitochondrial disease and was not on metformin hydrochloride, Type B lactic acidosis ... Nature.com Need To Know | Tata Motors says it isn't eyeing Mazda shares - Oct 13, 2008 Glynase by USV Pharma and Glyzip by Stadmed. The price of combination glipizide and metformin hydrochloride tablet has been increased by 1.3% to Rs9.38. Livemint Aurobindo gets European approvals - Jul 8, 2005 ...of the European Pharmacopoeia by the European Directorate for the Quality of Medicines for its active pharmaceutical ingredient Metformin Hydrochloride. ... Hindu Business Line Business in Brief - Apr 10, 2008 Depomed had sued Ivax in January 2006 claiming patent infringement by IVAX's Glucophage XR, or extended release metformin hydrochloride tablets for the ... Ha'aretz Depomed Enters into Promotion Agreement with Watson for ProQuin(R) … - Jul 23, 2007 Glumetza[TM] (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United ... $4.95 - Business Wire - ECNext Business Update; Generic drug-focused company announces US FDA … - Jan 11, 2005 Teva also announced that the FDA has granted tentative approval for the company's ANDA for Metformin Hydrochloride Extended Release Tablets, 750 mg. ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Steady stream of new products hits market. - Feb 4, 2008 Regulators cleared the company's abbreviated new drug application (ANDA) for glipizide/metformin hydrochloride tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg. ... $9.94 - Chain Drug Review - Alacra Store Business Update; Generic drug-focused company announces US FDA … - Jan 15, 2005 Teva also announced that the FDA has granted tentative approval for the company's ANDA for Metformin Hydrochloride Extended Release Tablets, 750 mg. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones New generics. - May 16, 2005 ...and TEVA Pharmaceuticals USA, North Wales, Pa., (888) TEVA USA, are introducing metformin hydrochloride extended-release tablets in 750-mg strength. ... $9.94 - Drug Topics - Alacra Store GlaxoSmithKline Medicines Halted - Mar 4, 2005 Avandamet (rosiglitazone maleate/metformin hydrochloride) tablets, used to treat type 2 diabetes, and Paxil CR (paroxetine hydrochloride controlled release) ... WebProNews GSK Revises US Labeling for Avandia(R). - Nov 14, 2007 ...including Avandamet (rosiglitazone maleate and metformin hydrochloride), and Avandaryl (rosiglitazone maleate and glimepiride). ... Free with registration - PR Newswire - AccessMyLibrary.com Depomed Announces Retirement of Chief Financial Officer John F. … - Oct 11, 2007 GLUMETZA(TM) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United ... $4.95 - Business Wire - ECNext GlaxoSmithKline; Company announces disruption of supply for Paxil CR ... - Apr 6, 2005 ...halted distribution of supplies of two of its medicines due to manufacturing issues: Avandamet (rosiglitazone maleate/metformin hydrochloride) tablets, ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones GlaxoSmithKline and FDA agree on consent decree. - Jun 1, 2005 ..."Avandamet" (combination rosiglitazone maleate and metformin hydrochloride, for diabetes)--seized by federal marshals at three locations last February. ... $9.94 - Pharmaceutical Technology - Alacra Store GlaxoSmithKline and FDA Reach Agreement on Consent Decree … - Apr 28, 2005 With respect to Paxil CR (paroxetine hydrochloride controlled release) tablets and Avandamet (rosiglitazone maleate / metformin hydrochloride) tablets, ... $4.95 - PR Newswire - ECNext Black-Box HF Warning for Thiazolidinediones - Aug 15, 2007 Avandamet (rosiglitazone maleate and metformin hydrochloride) tablets, Duetact (pioglitazone hydrochloride and glimepride) tablets. August 14, 2007. ... Medscape Depomed, Biovail Revise Partnership Agreement for Development, … - Dec 13, 2005 ...commercialization of Glumetza(tm), a once-daily, extended-release formulation of metformin hydrochloride (HCl) for the treatment of Type II diabetes. ... ccnmatthews.com GSK Announces Disruption of Supply for Paxil CR And Avandamet - Mar 8, 2005 ...of two of its medicines due to manufacturing issues: Avandamet (rosiglitazone maleate / metformin hydrochloride) tablets, used to treat type 2 diabetes, ... Medical News Today - Medical News Today (press release) Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR... - Jul 10, 2007 Glumetza[TM] (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United ... Free with registration - Business Wire - AccessMyLibrary.com Caraco изымает противодиабетичеÑ?кий препарат из продажи в СШÐ? - Mar 25, 2008 Metformin Hydrochloride, Ñ?влÑ?ющийÑ?Ñ? аналогом препарата Glucophage компании Bristol-Myers Squibb, поÑ?вилÑ?Ñ? на американÑ?ком фармрынке в феврале 2002 г. ... ФармацевтичеÑ?кий веÑ?тник Article: Business in brief - Jerusalem Post | HighBeam Research -... - Nov 1, 2005 Monday it received final approval from the the US Food and Drug Administration (FDA) for its ANDA for glipizide and metformin hydrochloride tablets. ... Pay-Per-View - Jerusalem Post - HighBeam Research Business in brief - Nov 1, 2005 Monday it received final approval from the the US Food and Drug Administration (FDA) for its ANDA for glipizide and metformin hydrochloride tablets. ... Pay-Per-View - Jerusalem Post - ProQuest Archiver BUSINESS BRIEFING - Apr 14, 2005 New Drug Application for metformin hydrochloride extended-release tablets. The generics manufacturer said it already has started shipping the product. ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |